NDC 51672-1402 – Calcipotriene and Betamethasone Dipropionate
Calcipotriene 50 ug/g; Betamethasone Dipropionate 50 mg/g · Suspension · Topical
Product NDC51672-1402
Product details
- Brand name
- Calcipotriene and Betamethasone Dipropionate
- Generic name
- Calcipotriene and Betamethasone Dipropionate
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- Suspension
- Route
- Topical
- Marketing category
- ANDA · ANDA213269
- Marketed since
- September 2, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Corticosteroid; Vitamin D Analog
Active ingredients
- Calcipotriene 50 ug/g
- Betamethasone Dipropionate 50 mg/g
Uses, dosage, side effects and warnings for Calcipotriene and Betamethasone Dipropionate →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 51672-1402-4 | 1 BOTTLE in 1 CARTON (51672-1402-4) / 60 g in 1 BOTTLE | Sep 2, 2020 |
| 51672-1402-8 | 2 BOTTLE in 1 CARTON (51672-1402-8) / 60 g in 1 BOTTLE | Sep 2, 2020 |
Other Calcipotriene and Betamethasone Dipropionate products
- 0713-0848 Betamethasone Dipropionate .5 mg/g; Calcipotriene 50 ug/g · Suspension · Cosette Pharmaceuticals, Inc.
- 63629-2520 Calcipotriene 50 ug/g; Betamethasone Dipropionate .643 mg/g · Ointment · Bryant Ranch Prepack
- 63629-8617 Calcipotriene 50 ug/g; Betamethasone Dipropionate .643 mg/g · Ointment · Bryant Ranch Prepack
- 72162-1428 Calcipotriene 50 ug/g; Betamethasone Dipropionate .643 mg/g · Ointment · Bryant Ranch Prepack
- 45802-816 Calcipotriene 50 ug/g; Betamethasone Dipropionate .643 mg/g · Ointment · Padagis Israel Pharmaceuticals Ltd
- 66993-938 Calcipotriene Monohydrate 50 ug/g; Betamethasone Dipropionate .5 mg/g · Ointment · Prasco Laboratories